Drug Profile
Hepatitis B immune globulin - China Biologic Products
Alternative Names: Human hepatitis B immunoglobulinLatest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator China Biologic Products
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Hepatitis B; Measles
Most Recent Events
- 25 Feb 2016 China Biologic Products withdraws registration application from the CFDA, for hepatitis B immunoglobin intravenous injection (China Biologic Products, Form 10-K, February 2016)
- 29 Oct 2015 Hepatitis B immune globulin is registered in China for Hepatitis B and Measles